Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Urinary Bladder Neoplasms 12Neoplasms 10Carcinoma, Renal Cell 9Ovarian Neoplasms 7Carcinoma, Transitional Cell 7Neoplasm Metastasis 6Pancreatic Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Merkel Cell 4Triple Negative Breast Neoplasms 3Recurrence 3Lymphoma 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Melanoma 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Kidney Diseases 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Urothelial Cancer 1Urologic Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1

Interventions

Rituximab 131Cyclophosphamide 74fludarabine phosphate 51Whole-Body Irradiation 38Peripheral Blood Stem Cell Transplantation 36Mycophenolic Acid 36Tacrolimus 32Etoposide 28Busulfan 28Melphalan 24Lenalidomide 23Prednisone 22Filgrastim 22Cyclosporine 22Bortezomib 22Antilymphocyte Serum 21Vincristine 19Methotrexate 19obinutuzumab 17Bendamustine Hydrochloride 16fludarabine 15Doxorubicin 15Radiotherapy 14ibrutinib 13Dexamethasone 13Cytarabine 13Cord Blood Stem Cell Transplantation 13Carmustine 13pembrolizumab 12idelalisib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Follicular × avelumab × Clear all
NCT03636503 2025-02-06

Rituximab + Immunotherapy in Follicular Lymphoma

Dana-Farber Cancer Institute

Phase 1 Terminated
24 enrolled 25 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡